| 1 |
Sung H，Ferlay J，Siegel RL，et al.Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin，2021，71(3)：209-249.
|
| 2 |
Gnutzmann D，Kortes N，Sumkauskaite M，et al.Transvascular therapy of Hepatocellular Carcinoma(HCC)，status and developments[J]. Minim Invasive Ther Allied Technol，2018，27(2)：69-80.
|
| 3 |
国家卫生健康委员会．原发性肝癌诊疗指南(2022年版)[J/OL]．中华普通外科学文献(电子版)，2022，16(2)：81-96.
|
| 4 |
中国抗癌协会肝癌专业委员会．肝动脉灌注化疗治疗肝细胞癌中国专家共识(2021版)[J]．中华消化外科杂志，2021，20(7)：754-759.
|
| 5 |
Obi S，Sato S，Kawai T．Current Status of Hepatic Arterial Infusion Chemotherapy[J]. Liver Cancer，2015，4(3)：188-199.
|
| 6 |
Massani M，Bonariol L，Stecca T．Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma，a Comprehensive Review[J]. J Clin Med，2021，10(12)：2552.
|
| 7 |
Lin D，Wu J．Hypoxia inducible factor in hepatocellular carcinoma：A therapeutic target[J]. World J Gastroenterol，2015，21(42)：12171-12178.
|
| 8 |
Sahu SK，Chawla YK，Dhiman RK，et al.Rupture of Hepatocellular Carcinoma：A Review of Literature[J]. J Clin Exp Hepatol，2019，9(2)：245-256.
|
| 9 |
中国医师协会介入医师分会临床诊疗指南专委会．中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南(2021年版)[J]．中华医学杂志，2021，101(24)：1848-1862.
|
| 10 |
Song JE，Kim DY.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma[J]. World J Hepatol，2017，9(18)：808-814.
|
| 11 |
Shi Q，Chen D，Zhou C，et al.Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma：A Single-Center Retrospective Study[J]. Cancer Mana Res，2020，12：5461-5468.
|
| 12 |
Pieper CC，Meyer C，Vilmar B，et al.Temporary arterial embolization of liver parenchyma with degradable starch microspheres(Mobcaps)in a swine model[J]. Cardiovasc Intervene Radios，2015，38(2)：435-441.
|
| 13 |
Harbord J，Reinholds MP，Wetter A，et al.DSM-TACE of HCC：Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional Therapies.DSM-TACE des HCC：Bewertung des Tumoransprechens von Patienten mit Kontraindikationen gegen andere systemische oder lokoregionale Therapien[J]. Rofo，2020，192(9)：862-869.
|
| 14 |
Irie T，Kuramochi M，Takahashi N．Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization：measurement of balloon-occluded arterial stump pressure[J]. Cardiovasc Intervent Radiol，2013，36(3)：706-713.
|
| 15 |
Soga S，Kuwamura H，Edo H，et al.Double Balloon-Occluded Transarterial Chemoembolization(Double B-TACE)for Hepatocellular Carcinomas Located in the Caudate Lobe[J]. Cardiovasc Intervent Radiol，2020，43(1)：162-164.
|
| 16 |
Hermann AL，DieudonnéA，Ronot M，et al.Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study[J]. Radiology，2020，296(3)：673-684.
|
| 17 |
Garin E，Lenoir L，Edeline J，et al.Boosted selective internal radiation therapy with 90Y-loaded glass microspheres(B-SIRT)for hepatocellular carcinoma patients：a new personalized promising concept[J]. Eur J Nucl Med Mol Imaging，2013，40(7)：1057-1068.
|
| 18 |
Yang P，Li N．Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm[J]. J Int Med Res，2022，50(7)：3000605221111281.
|
| 19 |
Li Z，Zhang K，Lin SM，et al.Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma：a systematic review and meta-analysis[J]. Int J Hyperthermia，2017，33(3)：237-246.
|
| 20 |
Lee S，Kang TW，Cha DI，et al.Radiofrequency ablation vs.surgery for perivascular hepatocellular carcinoma：Propensity score analyses of long-term outcomes[J]. J Hepatol，2018，69(1)：70-78.
|
| 21 |
Mohkam K，Dumont PN，Manichon AF，et al.No-touch multibipolar radiofrequency ablation vs.surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm[J]. J Hepatol，2018，68(6)：1172-1180.
|
| 22 |
Seki T，Wakabayashi M，Nakagawa T，et al.Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J]. Cancer，1994，74(3)：817-825.
|
| 23 |
Xu Y，Shen Q，Wang N，et al.Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma[J]. Chin J Cancer，2017，36(1)：14.
|
| 24 |
Gupta P，Maralakunte M，Kumar-M P，et al.Overall survival and local recurrence following RFA，MWA，and cryoablation of very early and early HCC：a systematic review and Bayesian network meta-analysis[J]. Eur Radiol，2021，31(7)：5400-5408.
|
| 25 |
Guo Y，Zhang Y，Klein R，et al.Irreversible electroporation therapy in the liver：longitudinal efficacy studies in a rat model of hepatocellular carcinoma[J]. Cancer Res，2010，70(4)：1555-1563.
|
| 26 |
Freeman E，Cheung W，Ferdousi S，et al.Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma：a single centre propensity-matched comparison[J]. Scand J Gastroenterol，2021，56(8)：942-947.
|
| 27 |
Jiang C，Cheng G，Liao M，et al.Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma：a time-to-event meta-analysis[J]. World J Surg Oncol，2021，19(1)：81.
|
| 28 |
Zaitoun MMA，Elsayed SB，Zaitoun NA，et al.Combined therapy with conventional trans-arterial chemoembolization(cTACE)and microwave ablation(MWA)for hepatocellular carcinoma>3-<5 cm[J]. Int J Hyperthermia，2021，38(1)：248-256.
|
| 29 |
Liu F，Meng Z，Shao G，et al.Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population：subgroup analysis of the GIDEON study[J]. Mol Biol Rep，2017，44(1)：149-158.
|
| 30 |
Zheng L，Fang S，Wu F，et al.Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma：A Retrospective Study[J]. Front Mol Biosci，2021，7：609322.
|
| 31 |
Im JH，Yoon SM，Park HC，et al.Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area[J]. Liver Int，2017，37(1)：90-100.
|
| 32 |
Chen L，Sun T，Kan X，et al.Transarterial chemoembolization combined with iodine-125 seed implantation for patients with hepatocellular carcinoma：a retrospective controlled study[J]. J Int Med Res，2020，48(10)：300060520944309.
|
| 33 |
Jin M，Yu Q，Liu Y，et al.Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma：A Meta-analysis[J]. J Clin Transl Hepatol，2021，9(2)：149-159.
|
| 34 |
Chen L，Ma X，Liu X，et al.Sorafenib combined with radiofrequency ablation as treatment for patients with hepatocellular carcinoma：a systematic review and meta-analysis[J]. J BUON，2017，22(6)：1525-1532.
|